Finance

Lists
Why is 605507 down 2,22%?
Dive Deeper
605507:SHA
Guobang Pharma Ltd
15,84 CN¥
-2,22%
(-0,36) 1D
16-окт., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605507...
Open
16,29 CN¥
High
16,54 CN¥
Low
15,71 CN¥
Mkt. cap
12,39 млд
Avg. vol.
8,69 млн
Volume
6,50 млн
Dividend
2,71%
Quarterly dividend
0,11 CN¥
Ex-dividend date
2026-ж., 29-май
P/E ratio
17,41
52-wk high
21,41 CN¥
52-wk low
14,34 CN¥
EPS
0,91 CN¥
No. of employees
4 миң
Open
16,29 CN¥
High
16,54 CN¥
Low
15,71 CN¥
Mkt. cap
12,39 млд
Avg. vol.
8,69 млн
Volume
6,50 млн
Dividend
2,71%
Quarterly dividend
0,11 CN¥
Ex-dividend date
2026-ж., 29-май
P/E ratio
17,41
52-wk high
21,41 CN¥
52-wk low
14,34 CN¥
EPS
0,91 CN¥
No. of employees
4 миң
News stories
From web sources and news partners
About Guobang Pharma Ltd
CEO-
Employees4,25 миң
Founded1996-ж., 29-мар.
Headquarters-
SectorPharmaceutical industry
Websitegbgcn.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,44 млд
1,54 млд
1,52 млд
1,62 млд
Cost of goods sold
1,04 млд
1,22 млд
1,17 млд
1,23 млд
Cost of revenue
1,04 млд
1,22 млд
1,17 млд
1,23 млд
Research and development expenses
56,01 млн
56,39 млн
29,72 млн
68,59 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
95,62 млн
91,84 млн
97,88 млн
102,20 млн
Operating expense
147,58 млн
163,74 млн
144,00 млн
181,88 млн
Total operating expenses
1,19 млд
1,38 млд
1,31 млд
1,42 млд
Operating income
251,14 млн
162,24 млн
206,77 млн
205,09 млн
Other non operating income
-6,09 млн
4,26 млн
-17,56 млн
15,56 млн
EBT including unusual items
253,57 млн
176,38 млн
187,17 млн
200,66 млн
EBT excluding unusual items
249,16 млн
157,04 млн
186,75 млн
187,38 млн
Income tax expense
39,67 млн
26,70 млн
27,04 млн
19,47 млн
Effective tax rate
15,65%
15,14%
14,45%
9,70%
Other operating expenses
-3,71 млн
17,40 млн
6,70 млн
16,35 млн
Net income
214,67 млн
150,58 млн
160,63 млн
180,72 млн
Net profit margin
14,87%
9,77%
10,56%
11,14%
Earnings per share
-
-
-
-
Interest and investment income
12,79 млн
6,57 млн
6,74 млн
4,95 млн
Interest expense
-5,20 млн
-6,86 млн
-9,19 млн
-1,98 млн
Net interest expenses
7,59 млн
-292,84 миң
-2,45 млн
2,97 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
359,34 млн
281,48 млн
326,01 млн
328,14 млн
Gain or loss from assets sale
-453,56 миң
-24,81 млн
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору